FDA Investigator Sinai Davis
Sinai Davis has inspections in 1 countries as of 14 Sep 2023. Sinai Davis has collaborated with a combinined 3026 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
97
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Alberto A Viciedo,
Alexandra A Carrico,
Allen Lou,
Amy L Singer,
Amy M Codella,
Amy M Cramer,
Ana S Cabrera,
Ankur C Patel,
Ann Marie Montemurro,
Annemarie B Randow,
Annemarie Bodnar,
Anthony J Donato,
Anthony M Criscuolo, Jr,
Anthony R Rauert,
Atul J Agrawal,
Barbara J Maulfair,
Barbara J Wilimczyk,
Barbara Jwilimczyk Macri,
Barbara L Rellahan, PhD,
Benjamin Bustamante,
Brandi L Garbutt,
Byungja E Marciante,
Cara M Minelli,
Cary Greene,
Charles J Chacko,
Charlotte P Chang,
Cheryl J Legrand,
Christian Parra,
Christina N Maurine,
Christina N Maurino,
Christine M Cerenzio,
Craig W Swanson,
Daniel J Grabicki,
David H Smith,
Dawn L Wydner,
Deborah B Nixon,
Denise M Visco, Investigator,
Dennis E Guilfoyle, PhD,
Dhaval H Patel,
Diane M Gubernot,
Douglas C Kovacs,
Dr. Zhou Chen (nmi), MD PhD,
Dung N Tran,
Edward Oshaughnessy,
Emest F Bizjak,
Emily A Walters,
Emmanuel J Ramos,
Eric J Cunningham,
Eric Rothschild,
Erin D Mccaffery,
Eufemia G Gonzalez,
Frank J Marciniak,
Frederick Razzaghi,
George Pyramides,
Gianine E Delade,
Gianine E Tompkins,
Guerlain Ulysse,
Haitao Li,
Helen B Ricalde,
Helen Verdel,
Herrmann,
Jacqueline Mdiaz Albertini,
Jason M Sluzynski,
Jay T Wong,
Jean M Kelahan,
Jeffrey J Ebersole,
Jennifer A Bazergui,
Jennifer Macmillan,
Jessica M Monteiro,
Johnna L Bleem,
Jonathan Ho,
Jonee J Mearns,
Jose M Cayuela,
Joseph F Mcginnis, RPh,
Joy F Canlas,
Joy Rkozlowski Klena,
Juanita P Versace,
Justin H Price,
Justine Tomasso,
Karen E D'orazio,
Karen F Tomaziefski,
Keith M Reilly,
Kelli F Dobilas,
Kelli Regente,
Kelly Doremus,
Kelly I Anderson,
Kerry A Kurdilla,
Kevin Obrien,
King,
Kinh Q Mac,
Krishnaiah Yellela,
Kristina L Conroy,
Kristy A Zielny,
Krystal O Ogunremi,
Kwong P Lee,
Laishan L Lam,
Larry Johnson,
Lata C Mathew, PhD,
Lawrence R Johnson,
Lcr Jayt Wong,
Li Li,
Liatte Kreuger, PharmD,
Liattle Krueger,
Lisa Harlan,
Lisa Mathew,
Loretta Nemchik,
Marcelo O Mangalindan, Jr,
Margaret M Sands,
Maria Estrella,
Maria Manzoni, PhD,
Marie T Falcone,
Marjorie D Schultz,
Melba T Rivera,
Melba Trivera Clavell,
Melissa B Libby,
Melissa T Roy,
Meredith L Sheridan,
Merril E Racke,
Meyer J Slobotsky,
Michael R Klapal,
Michael Serrano,
Miguel G Manzano,
Monika Borkowska,
Naakesh N Gomanie,
Nancy F Scheraga,
Nancy L Rolli,
Nerizza B Guerin,
Nicholas A Violand,
Niketa Patel,
Nikki S Ramirez,
Nina Yang,
Niraj Mehta,
Paul L Bellamy,
Peter R Lenahan,
Prabhu P Raju,
Regina T Brown,
Remache,
Richard D Manney,
Robert D Tollefsen,
Robert G Ruff,
Robert Sharpnack,
Rodrigo Vilchez,
Sachinkumar V Patel,
Sandra Kershaw,
Sands,
Sarah Adella Fave,
Sarah Forney,
Schultz,
Shahla Parvizi,
Sherri J Liu,
Shirley H Isbill,
Sidney B Priesmeyer,
Sinai I Davis,
State Agency,
Stephanie T Durso,
Stephen J Mottola,
Steven P Donald,
Susan M Halsted,
Tania E Garcia,
Tania E Vizcaino,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Tonia F Bernard,
Tressa T Lewis,
Valerie C Reed,
Wayne J Meyer,
William J Muszynski,
William R Chang,
Xiaohan Cai, PhD,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu
Sinai Davis's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2001 | FDA 483 | Community Blood Council of New Jersey, Inc. - Form 483, 2001-06-26 |
| September, 2002 | EIR | Blispak, Inc. - EIR, 2002-09-20 |
| May, 2003 | EIR | J. Knipper and Company, Inc. - EIR, 2003-05-19 |
| February, 2003 | EIR | Hoffmann La Roche Inc - EIR, 2003-02-21 |
| June, 2005 | EIR | Lycored Corp. - EIR, 2005-06-08 |
| February, 2003 | FDA 483 | Hoffmann La Roche Inc - Form 483, 2003-02-21 |
| August, 2003 | EIR | Actavis Elizabeth LLC - EIR, 2003-08-14 |
| June, 2003 | EIR | Concordia Clinical Research (IRB) - EIR, 2003-06-24 |
| June, 2001 | FDA 483 Response | Community Blood Council of New Jersey, Inc. - Form 483R, 2001-07-18 |
| November, 2002 | FDA 483 | EBI, LLC - Form 483, 2002-11-07 |
| August, 2001 | EIR | LTS Lohmann Therapy Systems Corp. - EIR, 2001-08-09 |
| April, 2003 | EIR | Bentley Laboratories, LLC - EIR, 2003-04-02 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more